FCH
BSX icon

Freestone Capital Holdings’s Boston Scientific BSX Stock Holding History

Freestone Capital Holdings’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-256
Closed -$9.2K – 482
2020
Q4 		$9.2K Buy
+256
New +$9.23K ﹤0.01% 871

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Freestone Capital Holdings's BSX Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 256 shares — an estimated $9.2K sold.

Freestone Capital Holdings first reported a position in BSX in Q4 2020 and held it in 1 quarter. The position peaked at $9.2K in Q4 2020. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 256 Boston Scientific shares in Q1 2021, an estimated $9.2K.
  • Freestone Capital Holdings first reported a position in Boston Scientific in Q4 2020 and held it in 1 quarter.
  • Freestone Capital Holdings's Boston Scientific position peaked at $9.2K in Q4 2020.
  • 830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.